A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability
Nature Biotechnology, Published online: 19 August 2026; doi:10.1038/s41587-026-03238-6 A prospective, blinded competition is conducted for artificial-intelligence-generated and optimized antibody discovery.
We haven't written up this one. Nature Biotechnology has the full story — the link below goes straight to it.